Skip to main content

Health advancement · Program portfolio

Health innovation needs an evidence path.

IHA’s health work spans workforce delivery, digital-health demonstrations, field partnerships, research questions, and future capital formation. This page reports those layers separately.

Three operating layers

Delivery, learning, and capital are not the same claim.

Each layer has a different accountable owner, maturity, and next proof.

Operating delivery

Workforce delivery

Accountable layer: Uplift Communities

Government-funded healthcare career pathways and connected learner-support infrastructure.

Demonstrated

Systems and product learning

Accountable layer: IHA

Care-management, navigation, and delivery models designed around explicit clinical and evidence boundaries.

In formation

Capital formation

Accountable layer: DeepFutures

A future capital layer for infrastructure and ventures; targets remain separate from raised or deployed capital.

Geography ledger

Where work happened—and where relationships are still forming.

New York City

Operating delivery

Healthcare workforce pathways delivered through Uplift Communities with public and education partners.

Kenya

Completed field work

A 14-day, three-city 2026 delegation documented through a public field archive.

South Africa & Caribbean

Relationship base

Partnership relationships and future opportunity are not presented as completed health deployments.

Evidence boundary

Demonstrated now

Operating workforce delivery in New York City, a public IHA Care demonstration, and completed Kenya 2026 field work documented across three cities.

Not yet claimed

Relationship geographies are not presented as active deployments. Product demonstrations and completed delegations are not presented as clinical outcomes or long-term systems change.

Next proof

Run governed pilots, define evaluation measures, document follow-on field commitments, and report outcomes by program rather than by broad geography.

Partner at a defined stage.

Delivery, research, clinical, technology, and funding partners should enter with a clear role and evidence responsibility.

Discuss a health partnership